Exazerbation der atopischen Dermatitis nach Behandlungsabbruch und prädiktive Faktoren für die Exazerbation: JAK1-Inhibitoren versus Dupilumab

IF 3.8 4区医学 Q1 DERMATOLOGY

Journal Der Deutschen Dermatologischen Gesellschaft Pub Date : 2025-06-11 DOI:10.1111/ddg.15688_g

Hanwen Wu, Jiling Zhu, Nali Yang, Xiaolin Ji, Zhenyan Li, Yiwen Zhou, Qiuyang Xu, Yahui Ye, Zicheng Bai, Jingying Wang, Zhiming Li

引用次数: 0

查看原文本刊更多论文

停止治疗后特应性皮炎加重及加重的预测因素：JAK1抑制剂与Dupilumab

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal Der Deutschen Dermatologischen Gesellschaft 医学-皮肤病学

CiteScore

3.50

自引率

25.00%

发文量

406

审稿时长

1 months

期刊介绍： The JDDG publishes scientific papers from a wide range of disciplines, such as dermatovenereology, allergology, phlebology, dermatosurgery, dermatooncology, and dermatohistopathology. Also in JDDG: information on medical training, continuing education, a calendar of events, book reviews and society announcements. Papers can be submitted in German or English language. In the print version, all articles are published in German. In the online version, all key articles are published in English.